Moderna debuted its banner on March 13 at the start of the national sport's two-week spring tournament - a simple white design with the company name in red

The US FDA had said it would approve drugs based on China-only trials. Last month it did a U-turn, arguing that single-country trials are a step backward in achieving the racial diversity the US needs.

The Australian biotechnology company and its peers have been fighting a ruling that banned Mexican citizens from entering the US to donate plasma.

The statement follows the US Securities Exchange Commission (SEC) identification of five Chinese stocks that will be delisted if they do not provide access to audit documents

No Indian company has publicly withdrawn from Russia and New Delhi has declined to condemn Moscow's invasion of Ukraine, despite pressure from the US

China is unlikely to join the majority of countries in approving foreign-made vaccines based on mRNA technology before making its own

The joint venture between Merck & Co and the Wellcome Trust said the plant would be part of a S$80 million ($58 million) development

One of the contenders is a team in China that last year was the first to complete a human trial of CRISPR genome-edited pig skin grafts

The biotech firm's shares were trading up 7% by mid-session, their biggest intraday gain since March 2020

The company will "explore partnerships in providing accurate, affordable and accessible cancer early detection to the Hong Kong and Greater Bay Area communities"

The recommendation, which sent Innovent shares down, raises concerns for other Chinese drugmakers seeking to bring products to the US market

Sintilimab, made by Suzhou-based Innovent and US drugmaker Eli Lilly, has been developed and commercialised under a global agreement